The Overlooked Population at Risk for AIN: Women With High-grade Lower Genital Tract Dysplasia or Cervical Cancer.
The purpose of this study is to determine the possibility and compliance of performing anal
Pap smear and Human Papilloma Virus (HPV) DNA testing on women with high grade lower genital
tract dysplasia or cervical cancer and determining the prevalence of anal dysplasia in this
population using a high-resolution anoscopy (HRA). In addition, it is being done to
potentially develop screening, diagnostic and treatment protocol for anal dysplasia in women
with high-grade lower genital tract dysplasia or cervical cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society